Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03043235 · ClinicalTrials.gov registry record
Race Adiposity Interactions Regulate Mechanisms Determining Insulin Sensitivity
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 126
- Enrollment target
NCT03043235 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 126 participants.
The verdict
NCT03043235 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 126 participants
- Enrollment target
Study Summary
This research study will examine how ethnic/racial background, body composition (%body fat), and the location of body fat affect the ability of the hormone insulin to promote uptake of blood sugar in persons who are 19 to 45 years of age. When insulin is ineffective in promoting blood sugar uptake, this condition is termed "insulin resistance." Insulin resistance plays a major role in the development of chronic metabolic diseases (such as type 2 diabetes, cardiovascular disease, and cancer), many of which differ with race. Previous studies suggest that insulin resistance is higher in African-Americans (AA) vs. European-Americans (EA). However, results from these studies remain unclear due to different testing measures used for insulin resistance as well as differences in body fat between individuals. Results from this research study may help explain why insulin resistance differs with genetic background and may guide development of personalized treatment strategies with implications for several chronic metabolic diseases (e.g., type 2 diabetes, cardiovascular disease, and cancer).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2014-01-08 |
| Est. Completion | 2018-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03043235
The ClinicalTrials.gov registry entry for NCT03043235 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03043235 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03043235 about?
NCT03043235 is a clinical study titled "Race Adiposity Interactions Regulate Mechanisms Determining Insulin Sensitivity". This research study will examine how ethnic/racial background, body composition (%body fat), and the location of body fat affect the ability of the hormone insulin to promote uptake of blood sugar in persons who are 19 to 45 years of age. When insulin is ineffective in promoting blood sugar uptake, ...
What is the current status of trial NCT03043235?
This trial is currently completed. The enrollment target is 126 participants. The study started on 2014-01-08. Estimated completion is 2018-06-30.
Who is sponsoring clinical trial NCT03043235?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.